Variant position: 467 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 489 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human TVIKAPTSFGYDKPHVLVDL LVDDSGKESLIGYRPTEDSKE
Mouse PVRKAPMASGYDKPHMLVDV LVDVGGKESLMGYRLTGEAQE
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
18 – 489 Interferon gamma receptor 1
267 – 489 Cytoplasmic
197 – 489 Missing. In isoform 2.
SeattleSNPs variation discovery resource;
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]; VARIANTS ILE-61; PRO-335 AND PRO-467;
Genomewide linkage analysis identifies polymorphism in the human interferon-gamma receptor affecting Helicobacter pylori infection.
Thye T.; Burchard G.D.; Nilius M.; Mueller-Myhsok B.; Horstmann R.D.;
Am. J. Hum. Genet. 72:448-453(2003)
Cited for: INVOLVEMENT IN SUSCEPTIBILITY TO HELICOBACTER PYLORI INFECTION; VARIANTS PRO-335 AND PRO-467;
A novel single-nucleotide substitution, Leu 467 Pro, in the interferon-gamma receptor 1 gene associated with allergic diseases.
Aoki M.; Matsui E.; Kaneko H.; Inoue R.; Fukao T.; Watanabe M.; Teramoto T.; Kato Z.; Suzuki K.; Suzuki Y.; Kasahara K.; Kondo N.;
Int. J. Mol. Med. 12:185-191(2003)
Cited for: VARIANT PRO-467;
Functional analysis of naturally occurring amino acid substitutions in human IFN-gammaR1.
van de Wetering D.; de Paus R.A.; van Dissel J.T.; van de Vosse E.;
Mol. Immunol. 47:1023-1030(2010)
Cited for: CHARACTERIZATION OF VARIANTS IMD27A GLU-61; GLY-63; CYS-66; PHE-77; TYR-77; TYR-85 AND THR-87; CHARACTERIZATION OF VARIANTS MET-14; ILE-61; LEU-149; PRO-335; MET-352 AND PRO-467; FUNCTION; MUTAGENESIS OF VAL-61;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.